NRx together with Osmind, Inc. conducted an in-person meeting attended by leadership of the FDA Division of Psychiatry Products and leadership of the FDA Center for Drug Evaluation and Research (CDER) ...
Figuring out how long it's taken the Multidisciplinary Association for Psychedelic Studies' (MAPS) application to reach the FDA’s desk all depends on when you start counting. The organization was ...
Please provide your email address to receive an email when new articles are posted on . ATA3219 is an allogeneic CAR T-cell therapy being investigated in the treatment of SLE with lupus nephritis. The ...
GlobalData on MSN
FDA issues CRL to Aldeyra’s reproxalap drug application
During the review process, the FDA provided label drafts in December 2025 and March 2026.
Please provide your email address to receive an email when new articles are posted on . Zabalafin Hydrogel is a novel, first-in-class, multi-target therapeutic plant-based drug. Phase 2b and phase 3 ...
According to the US FDA (https://www.fda.gov/industry/medical-products-rare-diseases-and-conditions/designating-orphan-product-drugs-and-biological-products). “NV ...
Baritinib is a drug to treat rheumatoid arthritis. After outbreak of COVID-19, Benevolent AI Company discovered that AAK1 is a regulatory factor in the process of SARS-CoC-2 infection by generating a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results